← All organizations

Mimetogen Pharmaceuticals USA, Inc.

Mimetogen Pharmaceuticals USA, Inc.

For profitWebsite ↗

Also known as: Mimetogen Pharmaceuticals USA, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 28, 2023

Timeline

2000s

Jan 1, 2004
Mimetogen Pharmaceuticals USA, Inc.— Founded

Drugs by trial phase (1 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

tavilermide

Indications

Studied for

Recent trials (9)

NCT05848128Lead sponsorPhase 3Jun 28, 2023
NCT03925727Lead sponsorPhase 3Mar 28, 2019
NCT02665234Study directorPhase 3Jan 1, 2016
NCT02665234Lead sponsorPhase 3Jan 1, 2016
NCT02634853Study directorPhase 3Dec 1, 2015
NCT02634853Lead sponsorPhase 3Dec 1, 2015
NCT01960010Lead sponsorPhase 3Oct 1, 2013
NCT01960010Study directorPhase 3Oct 1, 2013
NCT01257607Lead sponsorPhase 2Nov 1, 2010

Details

Founded: Montreal, CA Jan 1, 2004
Last known activity: Jun 28, 2023